Getinge B, SE0000202624

Getinge announces Life Science exit as Getinge stock costs EUR 22.90

Published on 10/15/2026 at 12:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eric Honroth leaves Getinge on October 31, 2026. Getinge stock costs EUR 22.90 on October 15, 2026 before the October 21 report.

Leadership and reporting dates

Eric Honroth's departure was announced on October 7, 2026.
Second-quarter 2026 revenue reached SEK 8.38 billion and net income was SEK 841.0 million.
Getinge stock trades at EUR 22.90 at 12:39 p.m. CEST at Lang & Schwarz on October 15, 2026.

Isometrische 3D-Grafik zeigt Wertschöpfungskette von Fertigung bis Patientenbett — Getinge AB (ISIN SE0000202624) veranschaulicht per 3D-Grafik die Wertschöpfungskette von Fertigung bis Patientenversorgung, Illustration mit AI erstellt.

Getinge (ISIN SE0000202624) was trading at EUR 22.90 at Lang & Schwarz on October 15, 2026 at 12:39 p.m. CEST as the company announced Eric Honroth's departure on October 7, 2026. According to Getinge, Honroth will leave his role as President Life Science on October 31, 2026, with an internal leader becoming acting president on November 1, 2026.

What changes after October 31

The leadership change affects Getinge's Life Science business, which supplies products and solutions for hospitals and life science institutions. The company said it had started identifying a successor and was assessing internal and external candidates in its October 7, 2026 release.

The timing puts execution alongside the next financial update. Getinge's second-quarter 2026 revenue was SEK 8.38 billion, up 1.70 percent from SEK 8.24 billion in the second quarter of 2025, while net income rose 61.00 percent to SEK 841.0 million, according to Simply Wall St.

Third-quarter report arrives October 21

Getinge will publish its third-quarter 2026 report on October 21, 2026 at 8:00 a.m. CEST and hold a conference call at 10:00 a.m. CEST. The schedule was announced by Getinge on October 7, 2026.

The immediate investor question is whether the next report can sustain the improvement shown in the second quarter. Nordea retained a Hold rating and a SEK 270.00 target on October 14, 2026, while expecting 2.00 percent organic growth and a 13.30 percent adjusted EBITA margin, according to MarketScreener. The bank also cited China as a challenging area and said much of the expected improvement was already reflected in the stock.

Stock sits near its yearly high

The Nasdaq Stockholm listing was quoted at SEK 255.80 at 10:41 a.m. UTC on October 15, 2026, with a 52-week range of SEK 175.90 to SEK 258.40. The current level is SEK 2.60 below the upper end of that range, leaving the October 21 report as the next scheduled company catalyst.

The next two dated events are Getinge's third-quarter report on October 21, 2026 and its annual report on January 26, 2027, according to the company's release and Affarsvarlden.

Euro quote before the report

Getinge stock was trading at EUR 22.90 at Lang & Schwarz on October 15, 2026 at 12:39 p.m. CEST. The next company date is October 21, 2026, when the third-quarter report is due.

The further course of trading is shown by the continuously updated real-time quote of Getinge stock.